Fundraising FoxAphelion Capital — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
ClearFlow develops PleuraFlow Active Clearance Technology, a device that maintains chest drain patency after cardiac surgery to reduce Retained Blood Syndrome complications, along with products for sternal fixation and reconstruction following sternotomy.
HardwareHealthtechMedical DevicesIrvine, US
Edward M. Boyle(Director)inPaul Molloy(Executive Officer, Director)inHannah Beathard(Executive Officer)in
BoardAlexander Suh(Director)inNed Scheetz(Director)inAndrew D. Firlik(Director)
Co-investorsCalifornia Technology VenturesOregon Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.